Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: a meta-analysis

BACKGROUND: Programmed cell death ligand 1 (PD-L1) has already been detected in various carcinomas. In non-Hodgkin lymphoma (NHL), however, the prognostic value of PD-L1 overexpression remains unclear. METHODS: A meta-analysis of 2321 NHL patients from 12 studies was performed. Hazard ratios (HRs) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Qiang, Liu, Zhigang, Liu, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986088/
https://www.ncbi.nlm.nih.gov/pubmed/31992262
http://dx.doi.org/10.1186/s12885-020-6550-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986088/
https://www.ncbi.nlm.nih.gov/pubmed/31992262
http://dx.doi.org/10.1186/s12885-020-6550-z

Ejemplares similares